Skip to content
TrialScanner

NCT05083260

NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa

Phase 1/Phase 2CompletedBIVILead

Registry record

Lead sponsor
BioVie Inc.
Conditions
Parkinson Disease
Primary completion
Nov 21, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05083260 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05083260: NE3107 Activity and Safety... | TrialScanner